Treatment of childhood peptic esophagitis: A double-blind placebo- controlled trial of nizatidine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 25, Issue 1, 1997, Pages 51-55

  Simeone, Domenico ^b   Caria, Maria Cristina ^a   Miele, Erasmo ^a   Staiano, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Pausilipon Hospital   (Italy)

Author keywords

H2 blockers; Nizatidine; Reflux esophagitis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EROSIVE GASTRITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REFLUX ESOPHAGITIS; STOMACH SECRETION; URTICARIA;

BIOPSY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; MALE; NIZATIDINE; PROSPECTIVE STUDIES;

MARTES PENNANTI;

EID: 0030803382     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199707000-00008     Document Type: Article

References (20)

1. Boyle JT. Gastroesophageal reflux in the pediatric patient. Gastroenterol Clin N Am 18:315-37.
2. Orlando RC. Reflux esophagitis. In: Yamada T, Alpers DH, Owyang C, et al, eds. Textbook of gastroenterology. Philadelphia: Lippincott, 1991:1123-47.
3. Kelly DA. Do H2 receptor antagonists have a therapeutic role in childhood? J Pediatr Gastroenterol Nutr 1994;19:270-6.
4. Morton DM. Pharmacology and toxicology of nizatidine. Scand J Gastroenterol 1987;22(suppl 136):1-8.
5. Cloud ML, Offen WW, et al. Nizatidine versus placebo in gastroesophageal reflux disease. A six week, multicenter, randomized, double-blind comparison. Dig Dis Sci 1992; 37:865-74.
6. Quick RPF, Cooper MJ, Gleeson M, et al. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1990;4:201-11.
7. Cucchiara S, Minella R, Iervolino C, et al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch Dis Child 1993;69:655-9.
8. Strobel CT, Byrne WJ, Ament ME, et al. Correlation of esophageal lengths in children with height: application to the Tuttle test without prior esophageal manometry. J Pediatr 1979;94:81-4.
9. Cucchiara S, Staiano A, Gobio-Casali L, Boccieri A, Paone FM. Value of the 24-hour intraesophageal pH monitoring in children. Gut 1990;31:129-33.
10. Cucchiara S, Gobio-Casali L, Balli F, et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. J Pediatr Gastroenterol Nutr 1989;8:150-6.
11. Minella R, Basile P, Staiano A, Cucchiara S. Ranitidine treatment in pediatrics. Med Univ 1989;2:1-5.
12. Scorza A, Conti-Nibali S, Sferlazzas C, et al. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis. Int J Clin Pharmacol Res 1990;10:179-82.
13. Oderda G, Dell'Olio D, Forni M, et al. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid. Ital J Gastroenterol 1990;22:346-9.
14. Dammann HG, Gottlieb WR, Walter TA, et al. The 24-hour acid suppression profile of nizatidine. Scand J Gastroenterol 1987;22(suppl 136):56-60.
15. Naccarato R, Cremer M, Dammann HG, et al. Nizatidine versus ranitidine in gastric ulcer disease. Scand J Gastroenterol 1987:22(suppl 136):71-8.
16. Simon B, Cremer M, Dammann HG, et al. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with acute duodenal ulcer: a multicenter study in Europe. Scand J Gastroenterol 1987;22(suppl 136):61-70.
17. Vandenplas Y. Reflux esophagitis in infants and children: A report from the working group on gastro-oesophageal reflux disease of the ESPGAN. J Pediatr Gastroenterol Nutr 1994;18:413-22.
18. Biller JA, Winter HS, Grand RJ, Alfre EN. Are endoscopic changes predictive of histologic esophagitis in children? J Pediatr 1983;103:215-8.
19. Lantz MD, Wozniak TJ. Stability of nizatidine in extemporaneous oral liquid preparations. Am J Hosp Pharm 1990;47:2716-9.
20. Delle Fave G, Annibale B, De Magistris E. Gastric pathophysiology of antisecretory drugs. Ital J Gastroenterol 1990;22(suppl 2):32-5.